Salmonella Outbreak: Recalled Super Greens Supplement Sickens 45

ago 1 hour
Salmonella Outbreak: Recalled Super Greens Supplement Sickens 45

Health officials have reported that a salmonella outbreak linked to a popular diet supplement has affected at least 45 individuals across nearly two dozen states. The incidents relate to the Super Greens brand of dietary supplement powder produced by Superfoods Inc., specifically the Live it Up line.

Details of the Salmonella Outbreak

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) confirmed that illnesses associated with the Super Greens products occurred between August 22 and December 30, 2025. Notably, at least 12 affected individuals required hospitalization, although fortunately, no deaths have been reported.

Recalled Products and Guidelines

Superfoods Inc. has initiated a recall for the Super Greens powder due to the potential health risks. The recalled items include:

  • Original flavor
  • Wild berry flavor

The expiration dates for these products range from August 2026 to January 2028. Consumers are advised against consuming, selling, or serving these supplements. Instead, they should dispose of the products or return them to the store where they were purchased.

States Affected by the Outbreak

The salmonella cases have been reported in 21 states, indicating widespread distribution of the affected products. The states experiencing reported illnesses include:

  • Alabama
  • Connecticut
  • Delaware
  • Iowa
  • Illinois
  • Kentucky
  • Massachusetts
  • Maine
  • Michigan
  • Minnesota
  • Missouri
  • Nebraska
  • New York
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Utah
  • Vermont
  • Washington
  • Wisconsin

Symptoms and Risks

Symptoms of salmonella infection typically manifest within hours or days after consuming contaminated products. Common symptoms include:

  • Diarrhea
  • Fever
  • Stomach cramps

While most healthy individuals recover within a week, the infection can pose serious risks for vulnerable groups, including young children, older adults, and individuals with compromised immune systems.

Continued Investigation

The FDA is conducting an ongoing investigation into this outbreak, and it has been indicated that additional products may be affected. Consumers are urged to stay informed and take necessary precautions.